Therapeutic Expertise
At MDL Clintech Limited, our clinical pharmacology, bioanalytical, and regulatory capabilities span key therapeutic areas central to global healthcare and generic drug development. We combine robust BE/BA study execution with advanced in vitro biowaiver strategies, delivering high-precision pharmacokinetic (PK) data and regulatory documentation tailored to the unique physiological and chemical challenges of each therapeutic class.
Oncology & Haematology
Evaluating oral oncology agents requires navigating narrow therapeutic windows, high pharmacokinetic variability, and stringent safety controls. MDL Clintech provides specialized BA/BE study designs in healthy volunteer cohorts or patient-based populations when ethically indicated. Our bioanalytical laboratories employ high-sensitivity LC-MS/MS platforms to quantify ultra-trace drug and active metabolite concentrations, while our regulatory team prepares robust justification packages and safety protocols compliant with global oncology guidance
Dermatology
Topical and dermatological formulations require specialized bioequivalence approaches to demonstrate local availability and systemic safety. We conduct standard BA/BE evaluations and leverage biowaiver pathways for line extensions and proportional strengths, ensuring seamless market entry for creams, gels, ointments, and oral therapies
Neuroscience & CNS
Central Nervous System (CNS) therapeutics, including antiepileptics, antidepressants, antipsychotics, and analgesics, often present complex absorption kinetics, significant first-pass metabolism, and central side-effect profiles. MDL Clintech manages both immediate- and modified-release CNS BA/BE studies with rigorous subject safety monitoring, standardized confinement conditions, and precise blood-sampling schedules to accurately characterize Cmax, Tmax, and elimination half-lives
Pulmonology
Inhalation and respiratory therapies require a distinct combination of in vitro characterization and clinical pharmacokinetics to establish therapeutic equivalence. MDL Clintech supports systemic oral pulmonary treatments (such as bronchodilators, leukotriene receptor antagonists, and modified-release xanthines). We conduct systemic bioavailability trials to ensure complete regulatory readiness across regional and international jurisdictions
Infectious Disease
From high-burden global health priorities, such as broad-spectrum antibiotics and novel antivirals, infectious disease therapeutics represent a core pillar of our expertise. We execute complex crossover and steady-state BA/BE trials evaluating food-effect interactions and fixed-dose combinations (FDCs). In parallel, we provide comprehensive BCS-based biowaiver evaluations (Class I and III), supporting WHO Prequalification dossiers and regional African registrations to accelerate access to essential anti-infectives
Cardiovascular
& Metabolic Disorders
Evaluating
cardiovascular and metabolic therapeutics demands rigorous glycemic and
hemodynamic monitoring, precise management of high intra-subject
pharmacokinetic variability, and careful evaluation of food effects on complex
formulations. MDL Clintech delivers robust BA/BE study designs, including
replicate crossover and steady-state evaluations for antihypertensives,
lipid-lowering agents, anticoagulants, and antidiabetic drugs. Our clinical
units are equipped with continuous vital monitoring and standardized meal
protocols to evaluate food-drug interactions accurately. Leveraging advanced
LC-MS/MS platforms, our bioanalytical team achieves ultra-sensitive
quantification of parent drugs, prodrug conversions, and active metabolites in
complex biological matrices, ensuring full alignment with global regulatory
standards
Gastroenterology
Assessing
gastrointestinal therapies requires addressing variable GI transit,
pH-dependent release, and pronounced food-effect dynamics inherent to delayed
and modified release formulations. MDL Clintech delivers robust BA/BE study
designs; including fasting, fed, and sprinkled-dose protocols for PPIs, 5-HT3
antagonists, and targeted GI therapeutics. Supported by controlled dietary
regimens and intensive early PK sampling, our specialized LC-MS/MS platforms
ensure precise, matrix-free quantification of acid-labile molecules and active
metabolites in full compliance with all global regulatory guidelines
Pain Management and Analgesics
Evaluating
analgesics and pain management therapeutics requires robust controls to
navigate rapid absorption kinetics, dose dumping in extended-release
formulations, and stringent subject safety profiles. We conducts comprehensive
BA/BE studies, including fasting, fed, and alcohol dose-dumping evaluations for
NSAIDs, opioid analgesics with naltrexone blockades, and neuropathic pain
agents. Supported by high-density early PK sampling and inpatient safety
monitoring, our advanced LC-MS/MS platforms deliver selective, high-sensitivity
quantification of parent drugs, enantiomers, and active metabolites
Endocrinology and Hormones
Tackling
Endogenous Complexity with Analytical Precision Endocrine BA/BE studies
require overcoming significant biological noise from fluctuating baseline
levels to circadian rhythm effects. MDL
Clintech solves this with robust baseline correction protocols and
strictly regulated in-house clinical monitoring. Our bioanalytical laboratories
deploy ultra-sensitive, stereoselective LC-MS/MS methods to reliably quantify
low-dose steroids, thyroid hormones, and synthetic analogs, delivering inspection-ready
data packages for global regulatory approval.
Women's Health & Gynaecology
Navigating
cyclical hormonal fluctuations and low systemic therapeutic concentrations
makes Women’s Health BA/BE studies uniquely demanding. We manages these variables through dedicated female and
post-menopausal volunteer databases and rigorous baseline-correction protocols.
Our bioanalytical laboratories deploy validated, stereoselective LC-MS/MS
platforms to reliably quantify synthetic estrogens, progestins, and
uterine-targeted therapeutics, delivering audit-ready data packages for global
regulatory filings
Modified-Release & Fixed-Dose Combinations
We
streamline bioequivalence testing for complex drug delivery systems. Whether
you are developing extended-release pellets, bilayer tablets, or multi-drug
combinations, MDL Clintech delivers the clinical precision needed for
challenging single- and steady-state PK profiles. Our simultaneous
multi-analyte LC-MS/MS methods maximize assay efficiency and sample turnaround,
ensuring faster approvals with zero regulatory compromise